Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Abstract

Among the viridans group streptococci, the Streptococcus mitis group is the most common cause of infective endocarditis. These bacteria have a propensity to be β-lactam resistant, as well as to rapidly develop high-level and durable resistance to daptomycin (DAP). We compared a parental, daptomycin-susceptible (DAPs) S. mitis/S. oralis strain and its daptomycin-resistant (DAPr) variant in a model of experimental endocarditis in terms of (i) their relative fitness in multiple target organs in this model (vegetations, kidneys, spleen) when animals were challenged individually and in a coinfection strategy and (ii) their survivability during therapy with daptomycin-gentamicin (an in vitro combination synergistic against the parental strain). The DAPr variant was initially isolated from the cardiac vegetations of animals with experimental endocarditis caused by the parental DAPs strain following treatment with daptomycin. The parental strain and the DAPr variant were comparably virulent when animals were individually challenged. In contrast, in the coinfection model without daptomycin therapy, at both the 106- and 107-CFU/ml challenge inocula, the parental strain outcompeted the DAPr variant in all target organs, especially the kidneys and spleen. When the animals in the coinfection model of endocarditis were treated with DAP-gentamicin, the DAPs strain was completely eliminated, while the DAPr variant persisted in all target tissues. These data underscore that the acquisition of DAPr in S. mitis/S. oralis does come at an intrinsic fitness cost, although this resistance phenotype is completely protective against therapy with a potentially synergistic DAP regimen.

• Authors: C Garcia-de-la-Maria, Y Q Xiong, J M Pericas, Y Armero, A Moreno, N N Mishra, M J Rybak, T T Tran, C A Arias, P M Sullam, A S Bayer, J M Miro
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 61 Issue 5 (05 2017) ISSN: 1098-6596 [Electronic] United States
• PMID: 28264848 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2017 American Society for Microbiology.

Chemical References

• Anti-Bacterial Agents
• Gentamicins
• Daptomycin

Topics

• Animals
• Anti-Bacterial Agents (therapeutic use)
• Daptomycin (therapeutic use)
• Drug Resistance, Bacterial (genetics)
• Drug Therapy, Combination
• Endocarditis, Bacterial (drug therapy, microbiology)
• Gentamicins (therapeutic use)
• Humans
• Microbial Sensitivity Tests
• Rabbits
• Streptococcal Infections (drug therapy, microbiology)
• Streptococcus mitis (drug effects, genetics, pathogenicity)